Parameters critical for the effector mechanism of anti-CD20 antibodies revisited

被引：1
|
作者：
Stasilojc, Grzegorz [1 ]
Felberg, Anna [1 ]
Okroj, Marcin [1 ]
机构：
[1] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, Gdansk, Poland
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 180卷 / 06期
关键词：
anti-CD20; antibodies; hybridoma formation; MONOCLONAL-ANTIBODIES; CD20; RITUXIMAB; EFFICACY; IMMUNOTHERAPY; CYTOTOXICITY; MALIGNANCIES; COMPLEMENT; RESISTANCE; THERAPY;
D O I：
10.1111/bjh.15130
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：777 / 779
页数：3
相关论文
共 50 条
  • [31] Molecular engineering of anti-CD20 antibodies for improved radioimmunotherapy.
    Raubitschek, AA
    Tan, G
    Wu, AM
    Forman, SJ
    [J]. BLOOD, 1998, 92 (10) : 249A - 249A
  • [32] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Sellebjerg, Finn
    Blinkenberg, Morten
    Sorensen, Per Soelberg
    [J]. CNS DRUGS, 2020, 34 (03) : 269 - 280
  • [33] The future of anti-CD20 monoclonal antibodies: are we making progress?
    Alduaij, Waleed
    Illidge, Tim M.
    [J]. BLOOD, 2011, 117 (11) : 2993 - 3001
  • [34] Cross-Reactivity of Antibodies to Rituximab with Other Therapeutic Anti-CD20 Antibodies
    Rispens, Theo
    Kuijpers, Taco W.
    Killestein, Joep
    van Kempen, Zoe L. E.
    Bloem, Karien
    [J]. JOURNAL OF IMMUNOLOGY, 2024, 212 (04): : 529 - 533
  • [35] Place of monoclonal antibodies (anti-CD52, anti-CD20) in chronic lymphocytic leukemia
    Divine, Marine
    [J]. HEMATOLOGIE, 2006, 12 : 35 - 38
  • [36] Novel humanized anti-CD20 monoclonal antibodies with unique germline VH and VL gene recruitment and potent effector functions
    Nishida, Michio
    Teshigawara, Keisuke
    Niwa, Otsura
    Usuda, Sadakazu
    Nakamura, Tetsuo
    Ralph, Peter
    Newman, Roland
    Padlan, Eduardo A.
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (06) : 1263 - 1274
  • [37] Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action
    Pescovitz, MD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 859 - 866
  • [38] Anti-CD20 antibodies to treat lymphoproliferative syndromes following renal transplantation
    Abderrahim, E
    Karoui, C
    Smaoui, W
    Raies, L
    Ben Abdallah, T
    Hedri, H
    Ben Moussa, F
    Bardi, R
    Ayed, K
    Ben Maïz, H
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (07) : 2708 - 2709
  • [39] Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies
    Li, Meng
    Yan, Zhen
    Han, Wei
    Zhang, Yingqi
    [J]. CELLULAR IMMUNOLOGY, 2006, 239 (02) : 136 - 143
  • [40] Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies
    Gasperini, Claudio
    Haggiag, Shalom
    Ruggieri, Serena
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (10) : 1243 - 1253
12345